Nephros, Inc. (NEPH)
NASDAQ: NEPH · Real-Time Price · USD
1.420
-0.060 (-4.05%)
Nov 4, 2024, 4:00 PM EST - Market closed

Company Description

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States.

It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.

The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment.

It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions.

The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Nephros, Inc.
Nephros logo
Country United States
Founded 1997
IPO Date Sep 21, 2004
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 31
CEO Robert Banks

Contact Details

Address:
380 Lackawanna Place
South Orange, New Jersey 07079
United States
Phone 201 343 5202
Website nephros.com

Stock Details

Ticker Symbol NEPH
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001196298
CUSIP Number 640671400
ISIN Number US6406714005
Employer ID 13-3971809
SIC Code 3841

Key Executives

Name Position
Robert Banks President, Chief Executive Officer and Director
Judy F. Krandel C.F.A. Chief Financial Officer
Alfred Vargas Director of Operations
Brianne McGuire Director of Brand, Marketing and Business Development
Vashone R. Thomas Vice President of Quality, Regulatory, and Human Resources

Latest SEC Filings

Date Type Title
Aug 26, 2024 8-K Current Report
Aug 8, 2024 10-Q Quarterly Report
Jun 17, 2024 S-8 Securities to be offered to employees in employee benefit plans
May 24, 2024 8-K Current Report
May 23, 2024 EFFECT Notice of Effectiveness
May 20, 2024 UPLOAD Filing
May 10, 2024 S-3 Registration statement under Securities Act of 1933
May 9, 2024 10-Q Quarterly Report
May 9, 2024 8-K Current Report
May 1, 2024 8-K Current Report